BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 29745035)

  • 41. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of whole-brain radiation therapy after stereotactic radiation surgery for brain metastases.
    Hasan S; Shah AH; Bregy A; Albert T; Markoe A; Stoyanova R; Thambuswamy M; Komotar RJ
    Pract Radiat Oncol; 2014; 4(5):306-315. PubMed ID: 25194099
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypofractionated adjuvant surgical cavity radiotherapy following resection of limited brain metastasis.
    Wijetunga A; Jayamanne D; Cook R; Parkinson J; Little N; Curtis J; Brown C; Back M
    J Clin Neurosci; 2020 Dec; 82(Pt A):155-161. PubMed ID: 33317725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patterns of distant brain recurrences after radiosurgery alone for newly diagnosed brain metastases: implications for salvage therapy.
    Zindler JD; Slotman BJ; Lagerwaard FJ
    Radiother Oncol; 2014 Aug; 112(2):212-6. PubMed ID: 25082096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypofractionated Stereotactic Radiotherapy for Patients with Intracranial Meningiomas: impact of radiotherapy regimen on local control.
    Meniai-Merzouki F; Bernier-Chastagner V; Geffrelot J; Tresch E; Lacornerie T; Coche-Dequeant B; Lartigau E; Pasquier D
    Sci Rep; 2018 Sep; 8(1):13666. PubMed ID: 30209337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is stereotactic radiosurgery a rational treatment option for brain metastases from small cell lung cancer? A retrospective analysis of 70 consecutive patients.
    Yomo S; Hayashi M
    BMC Cancer; 2015 Mar; 15():95. PubMed ID: 25879433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy.
    Kocher M; Wittig A; Piroth MD; Treuer H; Seegenschmiedt H; Ruge M; Grosu AL; Guckenberger M
    Strahlenther Onkol; 2014 Jun; 190(6):521-32. PubMed ID: 24715242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postoperative stereotactic radiosurgery and hypofractionated radiotherapy for brain metastases using Gamma Knife and CyberKnife: a dual-center analysis.
    Kübler J; Wester-Ebbinghaus M; Wenz F; Stieler F; Bathen B; Mai SK; Wolff R; Hänggi D; Blanck O; Giordano FA
    J Neurosurg Sci; 2024 Feb; 68(1):22-30. PubMed ID: 32031357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.
    Minniti G; Esposito V; Clarke E; Scaringi C; Lanzetta G; Salvati M; Raco A; Bozzao A; Maurizi Enrici R
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):623-9. PubMed ID: 23683828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control.
    Prabhu R; Shu HK; Hadjipanayis C; Dhabaan A; Hall W; Raore B; Olson J; Curran W; Oyesiku N; Crocker I
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e61-6. PubMed ID: 22516387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Three or More Courses of Stereotactic Radiosurgery for Patients with Multiply Recurrent Brain Metastases.
    Kotecha R; Damico N; Miller JA; Suh JH; Murphy ES; Reddy CA; Barnett GH; Vogelbaum MA; Angelov L; Mohammadi AM; Chao ST
    Neurosurgery; 2017 Jun; 80(6):871-879. PubMed ID: 28327948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is local radiotherapy a viable option for patients with an opening of the ventricles during surgical resection of brain metastases?
    Scharl S; Kessel KA; Diehl C; Gempt J; Meyer B; Zimmer C; Straube C; Combs SE
    Radiat Oncol; 2020 Dec; 15(1):276. PubMed ID: 33303000
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
    Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
    Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cavity volume changes after surgery of a brain metastasis-consequences for stereotactic radiation therapy.
    Scharl S; Kirstein A; Kessel KA; Duma MN; Oechsner M; Straube C; Combs SE
    Strahlenther Onkol; 2019 Mar; 195(3):207-217. PubMed ID: 30386864
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Stereotactic Radiotherapy of the Resection Cavity After Surgery of Brain Metastases Compared to Postoperative Whole-Brain Radiotherapy (ESTRON)-A Single-Center Prospective Randomized Trial.
    El Shafie RA; Paul A; Bernhardt D; Hauswald H; Welzel T; Sprave T; Hommertgen A; Krisam J; Schmitt D; Klüter S; Schubert K; Klose C; Kieser M; Debus J; Rieken S
    Neurosurgery; 2018 Sep; 83(3):566-573. PubMed ID: 29528419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Role of Stereotactic Radiosurgery in the Management of Brain Metastases From a Health-Economic Perspective: A Systematic Review.
    Warsi NM; Karmur BS; Brar K; Moraes FY; Tsang DS; Laperriere N; Kondziolka D; Mansouri A
    Neurosurgery; 2020 Sep; 87(3):484-497. PubMed ID: 32320030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of radiation necrosis after hypofractionated stereotactic radiotherapy (HFSRT) for brain metastases: a single center retrospective study.
    Di Perri D; Tanguy R; Malet C; Robert A; Sunyach MP
    J Neurooncol; 2020 Sep; 149(3):447-453. PubMed ID: 32979130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.